Cochlear Limited OC5.F Stock
194.14 EUR
{{ price }}
-0.297865%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Medical Devices
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
12.78B EUR
LOW - HIGH [24H]
194.14
-
194.14 EUR
VOLUME [24H]
105 EUR
{{ volume }}
P/E Ratio
59.91
Earnings per share
3.24 EUR
Cochlear Limited Price Chart
Cochlear Limited OC5.F Financial and Trading Overview
| Cochlear Limited stock price | 194.14 EUR |
| Previous Close | 149.12 EUR |
| Open | 150.02 EUR |
| Bid | 149.7 EUR x 20000 |
| Ask | 150.6 EUR x 20000 |
| Day's Range | 150.02 - 150.02 EUR |
| 52 Week Range | 119.68 - 153.88 EUR |
| Volume | 40 EUR |
| Avg. Volume | 2 EUR |
| Market Cap | 9.88B EUR |
| Beta (5Y Monthly) | 0.454022 |
| PE Ratio (TTM) | 60.736843 |
| EPS (TTM) | 3.24 EUR |
| Forward Dividend & Yield | 1.9 (1.25%) |
| Ex-Dividend Date | March 21, 2023 |
| 1y Target Est | N/A |
OC5.F Valuation Measures
| Enterprise Value | 9.48B EUR |
| Trailing P/E | 60.736843 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.7681236 |
| Price/Book (mrq) | 5.7529626 |
| Enterprise Value/Revenue | 5.535 |
| Enterprise Value/EBITDA | 24.042 |
Trading Information
Cochlear Limited Stock Price History
| Beta (5Y Monthly) | 0.454022 |
| 52-Week Change | 18.89% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 153.88 EUR |
| 52 Week Low | 119.68 EUR |
| 50-Day Moving Average | 149.18 EUR |
| 200-Day Moving Average | 138.89 EUR |
OC5.F Share Statistics
| Avg. Volume (3 month) | 2 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 65.7M |
| Float | 65.45M |
| Short Ratio | N/A |
| % Held by Insiders | 0.49% |
| % Held by Institutions | 44.73% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.45 |
| Trailing Annual Dividend Yield | 0.97% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.7547 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 15.26% |
| Operating Margin (ttm) | 20.79% |
| Gross Margin | 74.88% |
| EBITDA Margin | 23.02% |
Management Effectiveness
| Return on Assets (ttm) | 9.08% |
| Return on Equity (ttm) | 15.17% |
Income Statement
| Revenue (ttm) | 1.71B EUR |
| Revenue Per Share (ttm) | 25.06 EUR |
| Quarterly Revenue Growth (yoy) | 7.90% |
| Gross Profit (ttm) | 1.24B EUR |
| EBITDA | 394.3M EUR |
| Net Income Avi to Common (ttm) | 261.4M EUR |
| Diluted EPS (ttm) | 2.47 |
| Quarterly Earnings Growth (yoy) | -16.40% |
Balance Sheet
| Total Cash (mrq) | 546.7M EUR |
| Total Cash Per Share (mrq) | 8.31 EUR |
| Total Debt (mrq) | 250.4M EUR |
| Total Debt/Equity (mrq) | 14.6 EUR |
| Current Ratio (mrq) | 2.834 |
| Book Value Per Share (mrq) | 26.077 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 340.6M EUR |
| Levered Free Cash Flow (ttm) | 187.9M EUR |
Profile of Cochlear Limited
| Country | Germany |
| State | NSW |
| City | Sydney |
| Address | 1 University Avenue |
| ZIP | 2109 |
| Phone | 61 2 9428 6555 |
| Website | https://www.cochlear.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 4500 |
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
Q&A For Cochlear Limited Stock
What is a current OC5.F stock price?
Cochlear Limited OC5.F stock price today per share is 194.14 EUR.
How to purchase Cochlear Limited stock?
You can buy OC5.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cochlear Limited?
The stock symbol or ticker of Cochlear Limited is OC5.F.
Which industry does the Cochlear Limited company belong to?
The Cochlear Limited industry is Medical Devices.
How many shares does Cochlear Limited have in circulation?
The max supply of Cochlear Limited shares is 65.83M.
What is Cochlear Limited Price to Earnings Ratio (PE Ratio)?
Cochlear Limited PE Ratio is 59.91975400 now.
What was Cochlear Limited earnings per share over the trailing 12 months (TTM)?
Cochlear Limited EPS is 3.24 EUR over the trailing 12 months.
Which sector does the Cochlear Limited company belong to?
The Cochlear Limited sector is Healthcare.